Correlation Between Morgan Stanley and Teva Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Morgan Stanley and Teva Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Morgan Stanley and Teva Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Morgan Stanley Direct and Teva Pharmaceutical Industries, you can compare the effects of market volatilities on Morgan Stanley and Teva Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Morgan Stanley with a short position of Teva Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Morgan Stanley and Teva Pharmaceutical.
Diversification Opportunities for Morgan Stanley and Teva Pharmaceutical
0.35 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Morgan and Teva is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Morgan Stanley Direct and Teva Pharmaceutical Industries in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Teva Pharmaceutical and Morgan Stanley is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Morgan Stanley Direct are associated (or correlated) with Teva Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Teva Pharmaceutical has no effect on the direction of Morgan Stanley i.e., Morgan Stanley and Teva Pharmaceutical go up and down completely randomly.
Pair Corralation between Morgan Stanley and Teva Pharmaceutical
Given the investment horizon of 90 days Morgan Stanley is expected to generate 5.86 times less return on investment than Teva Pharmaceutical. But when comparing it to its historical volatility, Morgan Stanley Direct is 3.79 times less risky than Teva Pharmaceutical. It trades about 0.08 of its potential returns per unit of risk. Teva Pharmaceutical Industries is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 1,580 in Teva Pharmaceutical Industries on October 14, 2024 and sell it today you would earn a total of 450.00 from holding Teva Pharmaceutical Industries or generate 28.48% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 98.39% |
Values | Daily Returns |
Morgan Stanley Direct vs. Teva Pharmaceutical Industries
Performance |
Timeline |
Morgan Stanley Direct |
Teva Pharmaceutical |
Morgan Stanley and Teva Pharmaceutical Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Morgan Stanley and Teva Pharmaceutical
The main advantage of trading using opposite Morgan Stanley and Teva Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Morgan Stanley position performs unexpectedly, Teva Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Teva Pharmaceutical will offset losses from the drop in Teva Pharmaceutical's long position.Morgan Stanley vs. Cars Inc | Morgan Stanley vs. Logan Ridge Finance | Morgan Stanley vs. Ameriprise Financial | Morgan Stanley vs. US Global Investors |
Teva Pharmaceutical vs. Magic Software Enterprises | Teva Pharmaceutical vs. MAGIC SOFTWARE ENTR | Teva Pharmaceutical vs. UPDATE SOFTWARE | Teva Pharmaceutical vs. STRAYER EDUCATION |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |